Orelabrutinib,Rituximab and Methotrexate in Newly-diagnosed Primary Central Nervous System Lymphoma(PCNSL)
Condition: Primary Central Nervous System Lymphoma Intervention: Drug: Orelabrutinib,Rituximab and Methotrexate Sponsor: Affiliated Hospital to Academy of Military Medical Sciences Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Academies | Hospitals | Lymphoma | Methotrexate | Primary CNS Lymphoma | Research | Rituxan